Multiple cytokine-induced acute respiratory distress syndrome with a diffuse large B cell lymphoma, not otherwise specified.

[1]  J. Romaldini,et al.  Changes of Serum Cytokines in Hyperthyroid Graves’ Disease Patients at Diagnosis and during Methimazole Treatment , 2010, Neuroimmunomodulation.

[2]  F. Tas.  The contribution of countries and world regions in productivity of oncological publication. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  N. Suttorp,et al.  Tumor necrosis factor-alpha-dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability. , 2005, Blood.

[4]  Simon C Watkins,et al.  Interleukin-6 production in hemorrhagic shock is accompanied by neutrophil recruitment and lung injury. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[5]  G. Ciliberto,et al.  Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. , 1997, Immunity.

[6]  F. Stentz,et al.  Clinical Investigations in Critical CarePersistent Elevation of Inflammatory Cytokines Predicts a Poor Outcome in ARDS: Plasma IL-1β and IL-6 Levels Are Consistent and Efficient Predictors of Outcome Over Time , 1995 .

[7]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[8]  C. Elbim,et al.  Priming of polymorphonuclear neutrophils by tumor necrosis factor alpha in whole blood: identification of two polymorphonuclear neutrophil subpopulations in response to formyl-peptides. , 1993, Blood.

[9]  A. Fowler,et al.  Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. , 1991, The American review of respiratory disease.

[10]  C. Dinarello.  The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. , 1991, The Journal of infectious diseases.

[11]  T. Kishimoto,et al.  The biology of interleukin-6. , 1989, Blood.

[12]  A. Malik,et al.  Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Larrick,et al.  Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. , 1987, Journal of immunology.

[14]  J. Vilček,et al.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[15]  M. Flick,et al.  Mechanisms of acute lung injury. What have we learned from experimental animal models? , 1986, Critical care clinics.

[16]  F. Burgener,et al.  Intrathoracic histiocytic lymphoma. , 1981, AJR. American journal of roentgenology.

[17]  M Tubiana,et al.  Report of the Committee on Hodgkin's Disease Staging Classification. , 1971, Cancer research.